story of the week
PD-L1 Tumor Proportion Score and OS From First-Line Pembrolizumab for Nonsquamous vs Squamous NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Thoracic Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
PD-L1 Tumor Proportion Score and Overall Survival From First-Line Pembrolizumab in Patients With Nonsquamous Versus Squamous Non-Small Cell Lung Cancer
J Thorac Oncol 2021 Aug 26;[EPub Ahead of Print], DB Doroshow, W Wei, S Gupta, J Zugazagoitia, C Robbins, B Adamson, DL RimmFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.